Skip to content

Author

F. Speetjens

We have 1 of 56 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jun 2026

Asymptomatic Cardiotoxicity After High-Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography.

Cardiotoxicity levels in cTnT and NT-proBNP levels increase significantly during treatment and can be valuable markers to improve the risk stratification of patients treated with high-dose anthracyclines and can be valuable markers to improve the risk stratification of patients treated with high-dose anthracyclines.

E. A. Polomski, F. Speetjens, J. Jukema et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.